Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 24 9 2019
medline: 28 4 2021
entrez: 24 9 2019
Statut: ppublish

Résumé

Current treatment options for older and relapsed or refractory (R/R) acute myeloid leukemia (AML) patients are limited and represent an unmet need. Based on preclinical studies showing strong anti-leukemic effects

Identifiants

pubmed: 31545113
doi: 10.1080/10428194.2019.1665664
pmc: PMC7552944
mid: NIHMS1632123
doi:

Substances chimiques

Hydrazines 0
Triazoles 0
selinexor 31TZ62FO8F
Decitabine 776B62CQ27
Azacitidine M801H13NRU

Banques de données

ClinicalTrials.gov
['NCT02093403']

Types de publication

Clinical Trial, Phase I Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

387-396

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188269
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197734
Pays : United States

Références

N Engl J Med. 1999 Sep 30;341(14):1051-62
pubmed: 10502596
Br J Haematol. 2013 Apr;161(1):117-27
pubmed: 23373539
Leukemia. 2016 Jan;30(1):190-9
pubmed: 26202935
Bioinformatics. 2016 May 15;32(10):1557-8
pubmed: 26803155
Leukemia. 2017 Jan;31(1):143-150
pubmed: 27211268
Blood. 2017 Jun 15;129(24):3175-3183
pubmed: 28468797
Leukemia. 2016 Dec;30(12):2364-2372
pubmed: 27323910
J Clin Oncol. 2003 Dec 15;21(24):4642-9
pubmed: 14673054
J Hematol Oncol. 2016 Aug 24;9(1):73
pubmed: 27557643
J Clin Oncol. 2016 Sep 10;34(26):3166-74
pubmed: 27458288
Blood. 2015 Apr 23;125(17):2689-92
pubmed: 25716206
Cytogenet Genome Res. 2013;141(1):1-6
pubmed: 23817294
Leuk Lymphoma. 2014 Jul;55(7):1533-7
pubmed: 24144313
Blood. 2012 Aug 30;120(9):1765-73
pubmed: 22677130
Clin Cancer Res. 2016 Dec 15;22(24):6142-6152
pubmed: 27358488
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7473-8
pubmed: 20368434
J Clin Oncol. 2016 Dec;34(34):4142-4150
pubmed: 26926685
Leuk Lymphoma. 2013 Sep;54(9):2003-7
pubmed: 23270581
Cancer Res. 2001 Oct 1;61(19):7233-9
pubmed: 11585760
Semin Cancer Biol. 2014 Aug;27:52-61
pubmed: 24631835
Blood. 2020 Jul 9;136(2):259
pubmed: 32645169

Auteurs

Bhavana Bhatnagar (B)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Qiuhong Zhao (Q)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Alice S Mims (AS)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Sumithira Vasu (S)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Gregory K Behbehani (GK)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Karilyn Larkin (K)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

James S Blachly (JS)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

William Blum (W)

Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA.

Rebecca B Klisovic (RB)

Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA.

Amy S Ruppert (AS)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Shelley Orwick (S)

The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Christopher Oakes (C)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Parvathi Ranganathan (P)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

John C Byrd (JC)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Alison R Walker (AR)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Ramiro Garzon (R)

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH